RISS 학술연구정보서비스

검색

인기 검색어

    다국어 입력

    http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

    변환된 중국어를 복사하여 사용하시면 됩니다.

    예시)
    • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
    • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
    닫기
    KCI등재 SCOPUS

    A Case of Paclitaxel-induced Maculopathy Treated with Methazolamide

    한글로보기

    https://www.riss.kr/link?id=A103856054

    • 0

      상세조회
    • 0

      다운로드
    서지정보 열기
    • 내보내기
    • 내책장담기
    • 공유하기
      • URL 복사
    • 오류접수
    인용문이 복사되었습니다.

    부가정보

    다국어 초록 (Multilingual Abstract) kakao i 다국어 번역

    54-year-old female patient who had been undergoing anti-cancer chemotherapy and radiotherapy for seven years after surgery for left breast cancer visited our clinic for visual disturbance in the right eye at nine months after paclitaxel administration. The best-corrected visual acuity was 0.5 in the right eye and 1.0 in the left eye. The patient was diagnosed with maculopathy due to paclitaxel administration based on the finding of cystoid macular edema in the right eyeon fundus examination and optical coherence tomography; however, no leakage was detected on fluorescein angiography. Thus, drug replacement was planned. On the other hand, no abnormal finding was observed in the left eye. However, as the anti-cancer effect of paclitaxel is significant, replacing paclitaxel with another agent was not warranted; therefore, maintenance therapy with methazolamide was performed before and after administering the anti-cancer agent. Aggravation of cystoid macular edema was prevented, and vision improvement was achieved by oral maintenance therapy with methazolamide. In addition, the same fundus findings as shown in the right eye were detected in the left eye at 16 months after paclitaxel administration. After administering methazolamide, macular thickness was reduced, and vision was improved in the left eye. Paclitaxel administration was discontinued due to cutaneous metastasis from the breast cancer, and another anti-cancer agent was then administered. No subsequent cystoid macular edema has occurred.
    번역하기

    54-year-old female patient who had been undergoing anti-cancer chemotherapy and radiotherapy for seven years after surgery for left breast cancer visited our clinic for visual disturbance in the right eye at nine months after paclitaxel administration...

    54-year-old female patient who had been undergoing anti-cancer chemotherapy and radiotherapy for seven years after surgery for left breast cancer visited our clinic for visual disturbance in the right eye at nine months after paclitaxel administration. The best-corrected visual acuity was 0.5 in the right eye and 1.0 in the left eye. The patient was diagnosed with maculopathy due to paclitaxel administration based on the finding of cystoid macular edema in the right eyeon fundus examination and optical coherence tomography; however, no leakage was detected on fluorescein angiography. Thus, drug replacement was planned. On the other hand, no abnormal finding was observed in the left eye. However, as the anti-cancer effect of paclitaxel is significant, replacing paclitaxel with another agent was not warranted; therefore, maintenance therapy with methazolamide was performed before and after administering the anti-cancer agent. Aggravation of cystoid macular edema was prevented, and vision improvement was achieved by oral maintenance therapy with methazolamide. In addition, the same fundus findings as shown in the right eye were detected in the left eye at 16 months after paclitaxel administration. After administering methazolamide, macular thickness was reduced, and vision was improved in the left eye. Paclitaxel administration was discontinued due to cutaneous metastasis from the breast cancer, and another anti-cancer agent was then administered. No subsequent cystoid macular edema has occurred.

    더보기

    참고문헌 (Reference)

    1 Grover S, "Topical dorzolamide for the treatment of cystoid macular edema in patients with retinitis pigmentosa" 141 : 850-858, 2006

    2 Farber MD, "Reduction of macular oedema by acetazolamide in patients with chronic iridocyclitis: a randomised prospective crossover study" 78 : 4-7, 1994

    3 Joshi MM, "Paclitaxel maculopathy" 125 : 709-710, 2007

    4 Spirn MJ, "Optical coherence tomography findings in nicotinic acid maculopathy" 135 : 913-914, 2003

    5 Miyake Y, "Hyperbaric oxygen and acetazolamide improve visual acuity in patients with cystoid macular edema by different mechanisms" 111 : 1605-1606, 1993

    6 Fishman GA, "Effect of methazolamide on chronic macular edema in patients with retinitis pigmentosa" 101 : 687-693, 1994

    7 Telander DG, "Cystoid macular edema with docetaxel chemotherapy and the fluid retention syndrome" 22 : 151-153, 2007

    8 Fishman GA, "Continued use of dorzolamide for the treatment of cystoid macular oedema in patients with retinitis pigmentosa" 91 : 743-745, 2007

    9 Semb KA, "Capillary protein leak syndrome appears to explain fluid retention in cancer patients who receive docetaxel treatment" 16 : 3426-3432, 1998

    1 Grover S, "Topical dorzolamide for the treatment of cystoid macular edema in patients with retinitis pigmentosa" 141 : 850-858, 2006

    2 Farber MD, "Reduction of macular oedema by acetazolamide in patients with chronic iridocyclitis: a randomised prospective crossover study" 78 : 4-7, 1994

    3 Joshi MM, "Paclitaxel maculopathy" 125 : 709-710, 2007

    4 Spirn MJ, "Optical coherence tomography findings in nicotinic acid maculopathy" 135 : 913-914, 2003

    5 Miyake Y, "Hyperbaric oxygen and acetazolamide improve visual acuity in patients with cystoid macular edema by different mechanisms" 111 : 1605-1606, 1993

    6 Fishman GA, "Effect of methazolamide on chronic macular edema in patients with retinitis pigmentosa" 101 : 687-693, 1994

    7 Telander DG, "Cystoid macular edema with docetaxel chemotherapy and the fluid retention syndrome" 22 : 151-153, 2007

    8 Fishman GA, "Continued use of dorzolamide for the treatment of cystoid macular oedema in patients with retinitis pigmentosa" 91 : 743-745, 2007

    9 Semb KA, "Capillary protein leak syndrome appears to explain fluid retention in cancer patients who receive docetaxel treatment" 16 : 3426-3432, 1998

    더보기

    분석정보

    View

    상세정보조회

    0

    Usage

    원문다운로드

    0

    대출신청

    0

    복사신청

    0

    EDDS신청

    0

    동일 주제 내 활용도 TOP

    더보기

    주제

    연도별 연구동향

    연도별 활용동향

    연관논문

    연구자 네트워크맵

    공동연구자 (7)

    유사연구자 (20) 활용도상위20명

    인용정보 인용지수 설명보기

    학술지 이력

    학술지 이력
    연월일 이력구분 이력상세 등재구분
    2024 평가 해외DB학술지평가 신청대상 (해외등재 학술지 평가)
    2021-01-01 등재 등재학술지 유지 (해외등재 학술지 평가) KCI등재
    2020-01-01 등재 등재학술지 선정 (재인증) KCI등재
    2019-12-01 등재 등재후보로 하락 (계속평가) KCI등재후보
    2010-01-01 등재 등재학술지 선정 (등재후보2차) KCI등재
    2009-01-01 등재 등재후보 1차 PASS (등재후보1차) KCI등재후보
    2007-01-01 등재 등재후보학술지 선정 (신규평가) KCI등재후보
    더보기

    학술지 인용정보

    학술지 인용정보
    기준연도 WOS-KCI 통합IF(2년) KCIF(2년) KCIF(3년)
    2016 0.11 0.11 0.12
    KCIF(4년) KCIF(5년) 중심성지수(3년) 즉시성지수
    0.1 0.13 0.482 0.03
    더보기

    이 자료와 함께 이용한 RISS 자료

    나만을 위한 추천자료

    해외이동버튼